Oscar Health, Inc. $OSCR Shares Purchased by Geode Capital Management LLC

Geode Capital Management LLC increased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,798,313 shares of the company’s stock after purchasing an additional 116,430 shares during the period. Geode Capital Management LLC’s holdings in Oscar Health were worth $68,964,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Oscar Health by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after purchasing an additional 540,851 shares in the last quarter. Thrive Capital Management LLC grew its stake in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares in the last quarter. American Century Companies Inc. grew its stake in shares of Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock worth $100,298,000 after purchasing an additional 2,495,691 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Oscar Health by 0.9% during the third quarter. Dimensional Fund Advisors LP now owns 3,718,765 shares of the company’s stock worth $70,400,000 after purchasing an additional 31,785 shares in the last quarter. Finally, Farallon Capital Management LLC grew its stake in shares of Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after purchasing an additional 2,163,000 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insiders Place Their Bets

In other news, CAO Victoria Baltrus sold 1,523 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $33,414.62. Following the completion of the sale, the chief accounting officer directly owned 214,589 shares of the company’s stock, valued at approximately $4,708,082.66. This represents a 0.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,859 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $216,306.46. Following the completion of the sale, the insider directly owned 218,096 shares of the company’s stock, valued at $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 189,660 shares of company stock valued at $4,283,140. 25.11% of the stock is owned by insiders.

Oscar Health Stock Performance

NYSE OSCR opened at $27.37 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $27.59. The company has a market capitalization of $8.25 billion, a PE ratio of -46.39, a P/E/G ratio of 1.71 and a beta of 2.37. The company has a fifty day moving average of $18.70 and a two-hundred day moving average of $16.16.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the prior year, the firm posted $0.92 earnings per share. Oscar Health’s revenue for the quarter was up 52.6% on a year-over-year basis. As a group, analysts expect that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Wolfe Research assumed coverage on shares of Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating for the company. Robert W. Baird upped their price objective on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday. Finally, Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective for the company in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $20.22.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.